Novel imaging biomarkers predict progression-free survival in stage 3 NSCLC treated with chemoradiation and durvalumab.K Jazieh,M Khorrami,AM Saad,MM Gad,VS Viswanathan,P FuJOURNAL OF CLINICAL ONCOLOGY(2021)引用 4|浏览5暂无评分AI 理解论文溯源树样例生成溯源树,研究论文发展脉络Chat Paper正在生成论文摘要